FOLEY HOAG LLP for SANOFI US SERVICES INC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 20, 2018 | $45,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Jul 20, 2018 | $45,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
-Issues related to H.R. 4996: "Vaccine Access Improvement Act of 2018"
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN CAREY | — |
| PAUL KIM | — |
Health Issues HCR
-Implementation of Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development -Implementation of 21st Century Cures (P.L. 114-255) -Issues related to pandemic and seasonal influenza vaccine development -Reauthorization of Pandemic and All Hazards Preparedness (P.L. 109-417) -Issues related to over-the-counter drug and cosmetic reform legislation -Issues related to Right to Try -Issues related to drug and insulin pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BARKER | — |
| BRIAN CAREY | — |
| PAUL KIM | — |
Medicare/Medicaid MMM
-Medicare Part B and D payment for drugs -Issues related to the repeal of the non-interference clause in Part D
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BARKER | — |
| BRIAN CAREY | — |
| PAUL KIM | — |
Budget/Appropriations BUD
-Issues related to H.R. 1625: "Consolidated Appropriations Act of 2018" -Issues related to H.R. 1892 "Bipartisan Budget Act of 2018" -Issues related to National Institute of Health funding -Issues related to Biomedical Advanced Research and Development Authority
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN CAREY | — |
| PAUL KIM | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.